CLNN
Clene Inc.
Price:  
6.13 
USD
Volume:  
82,081.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Clene Relative Valuation

-1076.6%
Upside

As of 2026-03-18, the Relative Valuation of Clene Inc. (CLNN) is (59.87) USD. This relative valuation is based on P/E multiples. With the latest stock price at 6.13 USD, the upside of Clene Inc. based on Relative Valuation is -1076.6%.

The range of the Relative Valuation is (53.74) - (62.45) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 19.1x - 23.6x 21.1x
Forward P/E multiples 18.3x - 22.2x 21.5x
Fair Price (53.74) - (62.45) (59.87)
Upside -976.7% - -1118.8% -1076.6%
6.13 USD
Stock Price
(59.87) USD
Fair Price

Clene Relative Valuation - Historical P/E Data

Date P/E
2026-03-13 -2.04
2026-03-12 -2.11
2026-03-11 -1.99
2026-03-10 -1.94
2026-03-09 -1.95
2026-03-06 -1.91
2026-03-05 -1.89
2026-03-04 -1.96
2026-03-03 -1.79
2026-03-02 -1.86
2026-02-27 -1.86
2026-02-26 -1.91
2026-02-25 -1.76
2026-02-24 -1.79
2026-02-23 -1.63
2026-02-20 -1.65
2026-02-19 -1.68
2026-02-18 -1.61
2026-02-17 -1.50
2026-02-13 -1.50
2026-02-12 -1.46
2026-02-11 -1.47
2026-02-10 -1.57
2026-02-09 -1.58
2026-02-06 -1.53
2026-02-05 -1.39
2026-02-04 -1.42
2026-02-03 -1.52
2026-02-02 -1.44
2026-01-30 -1.46
2026-01-29 -1.48
2026-01-28 -1.75
2026-01-27 -1.85
2026-01-26 -1.80
2026-01-23 -1.89
2026-01-22 -1.93
2026-01-21 -1.85
2026-01-20 -1.68
2026-01-16 -1.80
2026-01-15 -1.82
2026-01-14 -1.82
2026-01-13 -1.81
2026-01-12 -1.84
2026-01-09 -2.28
2026-01-08 -2.12
2026-01-07 -2.23
2026-01-06 -2.18
2026-01-05 -2.05
2026-01-02 -2.05
2025-12-31 -2.09